'I actually thought he was going to hit me': OpenAI cofounder speaks out at Musk v. Altman trial

Greg Brockman testified in federal court that Elon Musk allegedly demanded majority control of OpenAI in 2017, and that he feared Musk might physically attack him during the meeting. The testimony adds detail to Musk’s lawsuit accusing OpenAI and Sam Altman of breaching the company’s founding agreement and converting from nonprofit to for-profit structure. The case underscores governance and control risks around one of the most important AI companies, but it is unlikely to have immediate broad market impact.

Analysis

The market impact is less about the courtroom drama itself and more about the implied governance discount on OpenAI’s ecosystem. Any credible evidence that the company’s control structure was contested from the outset strengthens the case that AI capex will stay capital-hungry, politically sensitive, and structurally prone to board-level shocks rather than smooth product execution. That tends to favor diversified public AI beneficiaries with more stable governance and monetization paths over single-asset or personality-driven AI bets.

For TSLA, the second-order effect is reputational and optionality-based, not fundamental near-term earnings. Musk’s AI credibility matters more to xAI/future software attach than to core auto margins, but the testimony reinforces a narrative that his leadership attention is fragmented and that he may be more constrained in recruiting partners or capital for AI initiatives. If investors start to price a lower probability of Musk winning broad AI control rights, it trims upside to his AI platform ambitions while leaving downside in place from headline overhang and distraction risk.

For NYT, the catalyst is engagement, not direct financial exposure. High-profile governance trials can drive incremental attention and subscription conversion, but that benefit is usually brief unless it extends the legal saga with fresh revelations. The bigger opportunity is in adjacent public-market AI names that benefit from OpenAI’s governance uncertainty: enterprise software and cloud providers should capture the ‘picks-and-shovels’ flow if customers want exposure without single-company control risk.

Contrarian angle: the consensus may overestimate the permanence of this headline risk for TSLA while underestimating how little it changes OpenAI’s commercialization trajectory. Court testimony can dent sentiment for days to weeks, but unless it produces enforceable constraints on Musk’s AI ambitions, the trade is mostly a volatility event. The cleaner view is that governance uncertainty marginally increases the equity risk premium for the entire frontier-AI stack, but does not justify a structural de-rating of the broad AI demand curve.

Key Decisions for Investors

• Short-dated TSLA call overwrites or downside put spreads for the next 2-6 weeks: monetize elevated event volatility; risk/reward skews to modest downside if headline flow stays negative, with limited upside if the testimony fades.
• Pair trade: long MSFT or GOOGL vs short TSLA for 1-3 months: own the best-positioned public AI beneficiaries with durable capital access and low governance noise; TSLA remains the more headline-sensitive leg.
• Buy a small tactical long in NYT on any legal-news-driven dip for 1-2 weeks: this is an engagement-driven trade, not a thesis position; take profits quickly if volume spikes and headlines normalize.
• Add exposure to broad enterprise AI enablers (e.g., ORCL, AMZN, MSFT) on weakness over the next 1-2 months: if OpenAI governance looks unstable, customers and allocators will favor infrastructure and distribution over founder-led moonshots.
• Avoid initiating fresh long-dated TSLA AI optionality until the trial produces a cleaner legal path: the risk/reward on Musk-related AI upside is now more binary and less underwritten by governance certainty.